| An overview of the common methods used to measure treatment adherence LA Anghel, AM Farcas, RN Oprean Medicine and pharmacy reports 92 (2), 117, 2019 | 290 | 2019 |
| How many potential drug–drug interactions cause adverse drug reactions in hospitalized patients? C Bucşa, A Farcaş, I Cazacu, D Leucuta, A Achimas-Cadariu, C Mogosan, ... European journal of internal medicine 24 (1), 27-33, 2013 | 102 | 2013 |
| Medication adherence and persistence in patients with autoimmune rheumatic diseases: a narrative review LA Anghel, AM Farcaş, RN Oprean Patient preference and adherence, 1151-1166, 2018 | 71 | 2018 |
| Adverse drug reactions in clinical practice: a causality assessment of a case of drug-induced pancreatitis A Farcas, M Bojita J Gastrointestin Liver Dis 18 (3), 353-358, 2009 | 65 | 2009 |
| Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania A Farcas, A Sinpetrean, C Mogosan, M Palage, O Vostinaru, M Bojita, ... European Journal of Internal Medicine 21 (5), 453-457, 2010 | 63 | 2010 |
| Effects of branched-chain amino acids on parameters evaluating sarcopenia in liver cirrhosis: systematic review and meta-analysis A Ismaiel, C Bucsa, A Farcas, DC Leucuta, SL Popa, DL Dumitrascu Frontiers in Nutrition 9, 749969, 2022 | 26 | 2022 |
| Study design, process and outcome indicators of post‐authorization studies aimed at evaluating the effectiveness of risk minimization measures in the EU PAS Register A Farcas, M Huruba, C Mogosan British Journal of Clinical Pharmacology 85 (3), 476-491, 2019 | 22 | 2019 |
| Patient’s counselling and management of adverse drug reactions and drug interactions in the community pharmacy M Iancu, C Bucsa, A Farcas, D Leucuta, A Dincu, C Mogoșan, ... Farmacia 63 (1), 80-85, 2015 | 17 | 2015 |
| The prevalence of potential drug-drug interactions in the therapy of Romanian community pharmacy’s patients CD Bucsa, I Cazacu, AM Farcas, M Bojita Farmacia 60 (4), 510-6, 2012 | 16 | 2012 |
| Post-Marketing surveillance of statins—A descriptive analysis of psychiatric adverse reactions in EudraVigilance G Pop, A Farcaș, A Butucă, C Morgovan, AM Arseniu, M Pumnea, ... Pharmaceuticals 15 (12), 1536, 2022 | 12 | 2022 |
| Preventability analysis of adverse drug reactions detected in two internal medicine departments in Romania A Farcas, C Bucsa, A Sinpetrean, D Leucuta, C Mogosan, D Dumitrascu, ... Internal and emergency medicine 9, 187-193, 2014 | 12 | 2014 |
| Inclusion complex of enalapril maleate/beta-cyclodextrin. FT IR, X-ray diffraction, DSC and molecular modeling L Rus, D Constantinescu, F Dragan, A Farcas, I Kacsó, G Borodi, I Bratu, ... FARMACIA-BUCURESTI- 55 (2), 185, 2007 | 12 | 2007 |
| Patients reporting of suspected adverse reactions to antidepressants. A pilot methodological study AM Farcas, C Farah, MT Bojita Farmacia 58 (3), 255-263, 2010 | 11 | 2010 |
| A description of medicines-related safety issues evaluated through a referral procedure at the EU level after 2012 A Farcas, T Balcescu, L Anghel, C Bucsa, C Mogoșan Expert opinion on drug safety 19 (6), 755-762, 2020 | 10 | 2020 |
| The economic burden of constipation therapy A Albu, A Farcas, L David, DL Dumitrascu Medicine and Pharmacy Reports 92 (3), 261, 2019 | 10 | 2019 |
| An investigation on the association between sodium glucose co‐transporter 2 inhibitors use and acute pancreatitis: A VigiBase study I Frent, C Bucsa, D Leucuta, A Farcas, C Mogosan Pharmacoepidemiology and Drug Safety 30 (10), 1428-1440, 2021 | 9 | 2021 |
| Relationship between beliefs about medicines and adherence in elderly patients with cardiovascular and respiratory diseases: A cross-sectional study in Romania M Sipos, A Farcas, N Prodan, C Mogosan Patient education and counseling 104 (4), 911-918, 2021 | 9 | 2021 |
| Statistical reporting in pharmaceutical papers from Romanian journals DC Leucuța, T Drugan, A Farcaş, A Achimaș Farmacia 63 (3), 394-401, 2015 | 9 | 2015 |
| The current insight on dual reninangiotensin system blockade: a data review with a focus on safety A Farcaș, F Gligor, C Bucșa, C Mogoșan, M Bojiță, D Dumitrașcu Farmacia 63 (3), 325-333, 2015 | 9 | 2015 |
| Physicians’ attitude towards voluntary reporting of adverse drug reactions A Farcaş, C Macavei, M Bojiţă Farmacia 56 (5), 563-570, 2008 | 9 | 2008 |
